Review
Research progress of malignant tumor associated venous thromboembolism
Fan Jian, Zhao Jiayi, Zhou Cihang, Liu Baiqiu, Gao Xuefeng, Han Yiping
Published 2021-10-20
Cite as Int J Respir, 2021, 41(20): 1590-1596. DOI: 10.3760/cma.j.cn131368-20210308-00170
Abstract
Malignancy-associated venous thrombosis (VTE) formation is a major cause of death in patients with cancer, including arterial and venous thromboembolism.The risk of malignant tumors complicated with VTE is influenced by many factors, including cancer type, stage, treatment and other complications.Malignant tumor complicated with VTE have a higher risk of death because of atypical symptoms or the late malignant tumor in more misdiagnosis.There is a variety of primary and recurrent VTE risk model to evaluate the incidence of VTE early, but still other predictors need for the effect of model distinguishing VTE high-risk patients.This review focused at the epidemiology, risk factors, internal mechanisms of biomarkers, prevention and treatment of VTE associated with malignant tumors in the understanding of VTE.
Key words:
Malignant tumor; Venous thromboembolism; Biomarker; Mechanism
Contributor Information
Fan Jian
Department of General Practice, Changhai Hospital of the Navy Military Medical University, Shanghai 200433, China
Zhao Jiayi
Department of General Practice, Changhai Hospital of the Navy Military Medical University, Shanghai 200433, China
Zhou Cihang
Department of General Practice, Changhai Hospital of the Navy Military Medical University, Shanghai 200433, China
Liu Baiqiu
Department of General Practice, Changhai Hospital of the Navy Military Medical University, Shanghai 200433, China
Gao Xuefeng
Department of General Practice, Changhai Hospital of the Navy Military Medical University, Shanghai 200433, China
Han Yiping
Department of Respiratory and Critical Care, Changhai Hospital of the Navy Military Medical University, Shamnghai 200433, China
